Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
PUT
Invesco QQQ Trust
QQQ
$480B
| $431M | 0.11% |
+882,900
| New | +$418M |
|
202
Vanguard High Dividend Yield ETF
VYM
$81.8B
| $428M | 0.11% |
3,340,856
+86,780
| +3% | +$10.7M |
|
203
Avery Dennison
AVY
$13.2B
| $427M | 0.11% |
1,935,373
-111,480
| -5% | -$24.1M |
|
204
Bloom Energy
BE
$68.8B
| $426M | 0.11% |
40,363,610
-400,784
| -1% | -$4.75M |
|
205
AES
AES
$10.5B
| $423M | 0.11% |
21,051,990
-297,486
| -1% | -$5.26M |
|
206
CVS Health
CVS
$133B
| $420M | 0.11% |
6,682,168
-65,525
| -1% | -$3.82M |
|
207
Packaging Corp of America
PKG
$22.4B
| $415M | 0.11% |
1,928,271
+75,359
| +4% | +$15M |
|
208
WEC Energy
WEC
$35.2B
| $413M | 0.11% |
4,287,252
+46,008
| +1% | +$4.08M |
|
209
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.8B
| $413M | 0.11% |
4,120,354
+309,968
| +8% | +$29M |
|
210
Pultegroup
PHM
$24.7B
| $407M | 0.1% |
2,837,698
+670,922
| +31% | +$85.3M |
|
211
Hewlett Packard
HPE
$67B
| $405M | 0.1% |
19,812,059
+15,493,193
| +359% | +$296M |
|
212
AvalonBay Communities
AVB
$26.7B
| $396M | 0.1% |
1,756,152
-22,532
| -1% | -$4.87M |
|
213
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $388M | 0.1% |
6,424,007
+531,752
| +9% | +$31.7M |
|
214
Ecolab
ECL
$78.1B
| $387M | 0.1% |
1,515,122
-16,804
| -1% | -$4.11M |
|
215
Regeneron Pharmaceuticals
REGN
$77.6B
| $386M | 0.1% |
366,759
-8,119
| -2% | -$9.04M |
|
216
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
| $385M | 0.1% |
7,262,722
+990,984
| +16% | +$50.4M |
|
217
Target
TGT
$67B
| $384M | 0.1% |
2,461,762
+417,134
| +20% | +$62.1M |
|
218
Synaptics
SYNA
$4.14B
| $382M | 0.1% |
4,928,396
+114,114
| +2% | +$9.15M |
|
219
iShares Russell 2000 ETF
IWM
$82.3B
| $381M | 0.1% |
1,724,386
+268,262
| +18% | +$57.4M |
|
220
CSX Corp
CSX
$92.6B
| $380M | 0.1% |
10,992,980
-246,759
| -2% | -$8.37M |
|
221
O'Reilly Automotive
ORLY
$73.4B
| $377M | 0.1% |
4,913,775
-124,830
| -2% | -$9.17M |
|
222
Baxter International
BAX
$14.3B
| $372M | 0.1% |
9,803,133
+435,286
| +5% | +$16M |
|
223
F5
FFIV
$23.4B
| $369M | 0.09% |
1,675,870
-410,304
| -20% | -$79.5M |
|
224
Vanguard Russell 1000 Growth ETF
VONG
$44.6B
| $369M | 0.09% |
3,815,317
-470,149
| -11% | -$43.9M |
|
225
Centene
CNC
$31.6B
| $368M | 0.09% |
4,890,145
-16,987
| -0.3% | -$1.25M |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.